Lexeo Therapeutics, Inc. Common Stock (LXEO) — Defensive Interval Ratio
Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Defensive Interval Ratio of 3120 days as of March 2026. Defensive assets of $121.28 Million (cash $-, short-term investments $121.28 Million, receivables $-) cover 3120 days of daily cash needs of $38.87K/day. See LXEO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lexeo Therapeutics, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Lexeo Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 3120 days, meaning defensive assets of $121.28 Million can fund 3120 days of operations without new revenue. See net asset quality index of Lexeo Therapeutics, Inc. Common Stock to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Lexeo Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Lexeo Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LXEO market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2579 days | $118.77 Million | $46.05K/day | $- | $118.77 Million | ▲ +1197 days |
| 2024 | 1382 days | $86.50 Million | $62.59K/day | $- | $86.50 Million | ▲ +1382 days |
| 2023 | 0 days | $0.00 | $47.23K/day | $- | $0.00 | — |